• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM S.R.L. OPTIFORM PROSTHETIC MITRAL HEART VALVE; MECHANICAL HEART VALVE PROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM S.R.L. OPTIFORM PROSTHETIC MITRAL HEART VALVE; MECHANICAL HEART VALVE PROSTHESIS Back to Search Results
Model Number CPHV
Device Problem Difficult to Open or Close (2921)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/02/2022
Event Type  malfunction  
Event Description
The manufacturer was informed of the following event.Before implanting, the sizing was performed (using corcym sizer) with no problem and optiform prosthetic mitral heart valve f7-027 was chosen to be implanted.The valve was tested and no problem was identified.After implanting the valve, it was detected that the opening/closing of the valve leaflet was not smooth.As such, the valve was explanted and another f7-027 was planted.Reportedly, the procedure was completed well, and the patient outcome is fine.Based on the information received, almost total resection of the native valve was performed, but some chordae papillary muscle were kept.Reportedly, there was no abnormal patient geometries and no concomitant procedure was performed.
 
Manufacturer Narrative
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.The valve was returned to the manufacturer.The inspections performed on the returned valve confirmed the absence of manufacturing defects.The hydrodynamic testing on the cphv subassembly #27 of the valve f7-027 ¿ sn (b)(6) was performed.The valve showed a correct movement of the leaflets during opening and closing phases.No anomalies were observed both in hypotensive and in normotensive conditions.Based on the performed analysis the reported event cannot be explained by any factor intrinsic in the involved device.The leaflet immobilization cannot be attributed to any abnormal features of the explanted prosthesis.Phenomena of partial leaflet immobilization, that could induce an opening / closing difficulty, occurring to several models of mechanical valves, have been described in the clinical literature.Entrapment between the leaflets and the housing of unraveled sutures, long suture ends or strands of chordal tissue, prosthesis size mismatch, suboptimal valve orientation, peculiar hydraulic conditions in the heart are indicated as possible cause for this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFORM PROSTHETIC MITRAL HEART VALVE
Type of Device
MECHANICAL HEART VALVE PROSTHESIS
Manufacturer (Section D)
CORCYM S.R.L.
strada crescentino
saluggia, vercelli
Manufacturer (Section G)
CORCYM S.R.L.
strada crescentino
saluggia, vercelli
Manufacturer Contact
roberta lamberti
5005 north fraser way
burnaby, bc 
MDR Report Key15306951
MDR Text Key298762452
Report Number3005687633-2022-00134
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier08022057012852
UDI-Public(01)08022057012852(240)F7-027(17)261029
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P900060/S019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCPHV
Device Catalogue NumberF7-027
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/26/2022
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/03/2022
Initial Date FDA Received08/26/2022
Supplement Dates Manufacturer Received09/14/2022
Supplement Dates FDA Received10/10/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/29/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-